Difference between revisions of "Part:BBa K2839005"

 
(One intermediate revision by the same user not shown)
Line 39: Line 39:
 
This reaction forms the '''final plasmid''' TALEsp1-Psp1w1-pSB1C3 plasmid containing the '''Psp1w1 TALE stabilized promoter'''.
 
This reaction forms the '''final plasmid''' TALEsp1-Psp1w1-pSB1C3 plasmid containing the '''Psp1w1 TALE stabilized promoter'''.
  
===6. Results and characterization of TALE stabilized Promoters:===
+
===6.Results and characterization of TALE stabilized Promoters:===
  
 
We used the TALEsp1 Psp1W1 promoter (B0032) in order to stabilize the expression of the TetR gene of an heterologous gate.  
 
We used the TALEsp1 Psp1W1 promoter (B0032) in order to stabilize the expression of the TetR gene of an heterologous gate.  
Line 50: Line 50:
 
The construct was inserted in plasmid backbones with different ORIs (psc101,p15A,  pUC19-derived pMB1) and transformed into DH5a cells. After that, colony PCR was performed in order to identify the colonies with the correct insert. Single colonies were picked and prepared to be measured.
 
The construct was inserted in plasmid backbones with different ORIs (psc101,p15A,  pUC19-derived pMB1) and transformed into DH5a cells. After that, colony PCR was performed in order to identify the colonies with the correct insert. Single colonies were picked and prepared to be measured.
  
:*'''Flow cytometry measurements: '''
+
:*'''Flow Cytometry Results'''
  
:'''Sample preparation'''
+
[[Image:Flowcyt.png]]
  
:In order to prepare the cultures for flow cytometry measurements we followed the protocol created by Adam Mayer et al  [1]. In particular the correct colonies were inoculated into 1 ml Lb + antibiotics and grown overnight at 37 °C in a shaking incubator adjusted to 250 rpm.The overnight growths were diluted 1:200 into 1 ml LB + antibiotics and grown at 37 °C into shaking incubator .After 2 hours the growths were diluted 1:500 into prewarmed LB + antibiotics + inducer where necessary and grown at 37 °C, 250 rpm for 5 hours.After growth, 20 μl of culture sample was diluted into 180 μl PBS + 200 μg/ml kanamycin to inhibit translation. The samples were stored at 4°C for 1 hour and then measurements were performed using the CyFlow Cube8 Sysmex Partec Flow Cytometer.
+
:''Fig1: TALE1sp1 Pupsp1, TALEsp2 Pupsp2, non stabilized constitutive pT7A1w1 promoter flowcytometry fluorescence measurements at three different copy numbers. Error bars represent standard deviation from three biological replicates.''  
 
+
:'''Flow Cytometry Results'''
+
 
+
[[Image:Screen_Shot_2018-10-17_at_7.23.45_PM.png]]
+
  
 
:*'''Plate Reader Measurements'''
 
:*'''Plate Reader Measurements'''
 
:For the plate reader measurements and sample preparation we followed the the iGEM 2018 InterLab Study Protocol.  
 
:For the plate reader measurements and sample preparation we followed the the iGEM 2018 InterLab Study Protocol.  
  
[[Image:Screen_Shot_2018-10-17_at_7.24.01_PM.png]]
+
[[Image:Measur.png]]
  
 +
:''Fig2: TALE1sp1 Pupsp1, TALEsp2 Pupsp2, non stabilized constitutive pT7A1w1 promoter Plate Reader fluorescence measurements at three different copy numbers. Error bars represent standard deviation from three biological replicates. ''
 
:The results demonstrate that sfGFP expression level, under the control of TALEsp1-Pupsp1 stabilized promoter (BBa_K2839000) and TALEsp2-Pupsp2 stabilized promoter (BBa_K2839014), does not significantly change when expressed from vectors with different copy number. Whereas, sfGFP expression driven from a non stabilized constitutive promoter changes when different copy number plasmids are used for its expression.
 
:The results demonstrate that sfGFP expression level, under the control of TALEsp1-Pupsp1 stabilized promoter (BBa_K2839000) and TALEsp2-Pupsp2 stabilized promoter (BBa_K2839014), does not significantly change when expressed from vectors with different copy number. Whereas, sfGFP expression driven from a non stabilized constitutive promoter changes when different copy number plasmids are used for its expression.
  
 
: 2 '''Interlaboratory Collaboration Measurement Study:'''
 
: 2 '''Interlaboratory Collaboration Measurement Study:'''
 
:This part was used as the Test Device 3 in our [[http://2018.igem.org/Team:Thessaloniki/Collaborations/ Interlaboratory variation Collaboration]].
 
:This part was used as the Test Device 3 in our [[http://2018.igem.org/Team:Thessaloniki/Collaborations/ Interlaboratory variation Collaboration]].
 +
 +
===References===
 +
 +
:[1]Brophy, J. A. N., & Voigt, C. A. (2014). Principles of genetic circuit design. Nature Methods. https://doi.org/10.1038/nmeth.2926
 +
:[2]Segall-Shapiro, T. H., Sontag, E. D., & Voigt, C. A. (2018). Engineered promoters enable constant gene expression at any copy number in bacteria. Nature Biotechnology. https://doi.org/10.1038/nbt.4111
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Latest revision as of 21:14, 17 October 2018


Talesp1-Psp1w1 stabilized promoter (B0032)

1.Short description:

Constructs-Psp1w32.jpg

This part consists of a TAL Effector (TALEsp1), a TALEsp1-stabilized promoter (psp1w1) and a fluorescent marker (sfGFP). This part was originally designed by Thomas Hale Segall-Shapiro (Shapiro et al) and iGEM Thessaloniki modified it to exclude 2 PstI recognition sites, thus making it RFC[10] compatible .It can be used to achieve stabilised expression of the sfGFP marker, decoupled from gene/plasmid copy number.

2.Biology and Functionality:

Transcription Activator- Like Effectors (TAL Effectors or TALEs) are DNA binding proteins that are naturally expressed by members of the Xanthomonas genus when infecting plants. They contain a central repeat domain which defines their binding to specific promoter sequences in the plant genome, activating transcription and facilitating the bacterial infection.
Because of their modular architecture and their ability to recognise specific promoter sequences, TALEs are widely used in genome editing when precise targeting is required. They can be programmed/designed to tightly bind to target sites operating as transcription factors by either activating or repressing transcription initiation or elongation. and either activate or repress transcription.(1)
  • DNA binding proteins
  • Modular Architecture
  • Precise Binding with negligible off target effects

3.Usage in our Project:

As a chassis for hosting the system’s devices we use DH5a E.coli cells. We utilize the ability of the TAL effectors to bind to specific promoter sequences and act as repressors by preventing the recruitment of the RNA polymerase in order to create a type I incoherent Feedforward Loop (iFFL) network motif that renders the expression of the downstream sequences independent of the plasmid’s copy number. A promoter under this effect is called a Stabilized Promoter.
Copy number positively affects GOI expression, while its repressor, being under the same positive influence, compensates for this change. If the hill coefficient that characterizes the repression is 1, and thus the repression is perfectly non-cooperative, it results in the disassociation of the GOI’s expression from the plasmid’s copy number.
Each stabilized promoter is characterized by its Strength, the Gene of Interest expression level and Error, the relative change in the Gene of Interest expression as the Copy number increases from the lowest to the highest Copy Number measured. As the expression level of the Repressor increases, the stabilization Error

and the promoter’s Strength decrease, leading to weaker but more stable expression across different copy numbers.

TALEsp1 protein does not interfere with the host's native genetic circuitry. It tightly binds to it’s operator and leads to a stable expression of the downstream fluorescent marker decoupled from plasmid copy number.

4.RFC[10] Compatibility, Illegal Sites Removal:

The original sequence by Shapiro et al. contains 2 PstI illegal sites, which we removed in order to make the part RCF[10] compatible. We achieved this by using 2 sets of primers with BsaI site overhangs, each with the function of removing one PstI recognition site.

5.Cloning Strategy:

The following procedure has been followed in order to replace the Pupsp1 stabilized promoter with the Psp1w1 stabilized promoter .The expression level of sfGFP driven by the Psp1w1 promoter are lower than the sfGFP expression levels driven by the Pupsp1 promoter.
Steps
  • PCR amplification of Psp1w1-pSB1C3 plasmid with In1, In2 primers.

These primers amplify the Psp1w1 promoter characterization device and incorporate BsaI sites flanking the amplified device.

  • PCR amplification of TALEsp1-pSB1C3 vector with Ri1, Ri2 primers.

These primers amplify the TALEsp1 cassette together with the plasmid backbone and incorporate BsaI restriction sites at the external regions of the amplified sequence. Restriction digestion with BsaI of the previously amplified sequences creates sticky complementary ends and thus they can be assembled together.

  • Restriction digestion with BsaI restriction enzyme of the previously amplified sequences creates sticky complementary ends and thus they can be assembled together.

This reaction forms the final plasmid TALEsp1-Psp1w1-pSB1C3 plasmid containing the Psp1w1 TALE stabilized promoter.

6.Results and characterization of TALE stabilized Promoters:

We used the TALEsp1 Psp1W1 promoter (B0032) in order to stabilize the expression of the TetR gene of an heterologous gate.

Results of TALE stabilized promoters:

We measured the fluorescence intensity of the constructs in different plasmid backbones with different copy numbers to investigate their performance in promoter stabilization and its correspondence with expected results.
For the sfGFP fluorescence intensity measurements flow cytometry was our primary measuring method, while a plate reader was also used. All measurements were performed in biological replicates (n=3) and cells were maintained at mid-log phase, unless other stated. Sample preparation, technical details and the raw data can be found in our [http://2018.igem.org/Team:Thessaloniki/Experiments/ protocol] and [http://2018.igem.org/Team:Thessaloniki/Results/ results ] pages, respectively.
1 Different Copy number Measurements:
Fluorescence intensity measurements of this construct were conducted in DH5α E. coli cells to determine the functionality of promoter stabilization over different copy numbers.

The construct was inserted in plasmid backbones with different ORIs (psc101,p15A, pUC19-derived pMB1) and transformed into DH5a cells. After that, colony PCR was performed in order to identify the colonies with the correct insert. Single colonies were picked and prepared to be measured.

  • Flow Cytometry Results

Flowcyt.png

Fig1: TALE1sp1 Pupsp1, TALEsp2 Pupsp2, non stabilized constitutive pT7A1w1 promoter flowcytometry fluorescence measurements at three different copy numbers. Error bars represent standard deviation from three biological replicates.
  • Plate Reader Measurements
For the plate reader measurements and sample preparation we followed the the iGEM 2018 InterLab Study Protocol.

Measur.png

Fig2: TALE1sp1 Pupsp1, TALEsp2 Pupsp2, non stabilized constitutive pT7A1w1 promoter Plate Reader fluorescence measurements at three different copy numbers. Error bars represent standard deviation from three biological replicates.
The results demonstrate that sfGFP expression level, under the control of TALEsp1-Pupsp1 stabilized promoter (BBa_K2839000) and TALEsp2-Pupsp2 stabilized promoter (BBa_K2839014), does not significantly change when expressed from vectors with different copy number. Whereas, sfGFP expression driven from a non stabilized constitutive promoter changes when different copy number plasmids are used for its expression.
2 Interlaboratory Collaboration Measurement Study:
This part was used as the Test Device 3 in our http://2018.igem.org/Team:Thessaloniki/Collaborations/ Interlaboratory variation Collaboration.

References

[1]Brophy, J. A. N., & Voigt, C. A. (2014). Principles of genetic circuit design. Nature Methods. https://doi.org/10.1038/nmeth.2926
[2]Segall-Shapiro, T. H., Sontag, E. D., & Voigt, C. A. (2018). Engineered promoters enable constant gene expression at any copy number in bacteria. Nature Biotechnology. https://doi.org/10.1038/nbt.4111

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal XhoI site found at 2734
    Illegal XhoI site found at 3671
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 1707
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 23